Peter Kupchak

804 total citations
17 papers, 624 citations indexed

About

Peter Kupchak is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Peter Kupchak has authored 17 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 5 papers in Neurology. Recurrent topics in Peter Kupchak's work include Genetic Neurodegenerative Diseases (5 papers), Neurological disorders and treatments (4 papers) and Advanced Proteomics Techniques and Applications (2 papers). Peter Kupchak is often cited by papers focused on Genetic Neurodegenerative Diseases (5 papers), Neurological disorders and treatments (4 papers) and Advanced Proteomics Techniques and Applications (2 papers). Peter Kupchak collaborates with scholars based in Canada, United States and United Kingdom. Peter Kupchak's co-authors include Inga Kireeva, George Jackowski, John Marshall, Rulin Zhang, Eric Stanton, Kenneth Evans, Michèle Rasamoelisolo, Christopher R. Smith, Deborah Pinchev and Weimin Zhu and has published in prestigious journals such as PLoS ONE, Clinical Chemistry and Molecular Therapy.

In The Last Decade

Peter Kupchak

17 papers receiving 606 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Kupchak Canada 11 360 201 124 74 65 17 624
Hari Kosanam Canada 11 278 0.8× 97 0.5× 68 0.5× 35 0.5× 51 0.8× 20 472
Sara Hansson Sweden 12 405 1.1× 111 0.6× 59 0.5× 88 1.2× 378 5.8× 22 777
Marcel P. Stoop Netherlands 18 554 1.5× 221 1.1× 54 0.4× 32 0.4× 124 1.9× 29 953
Antti Jylhä Finland 15 280 0.8× 58 0.3× 97 0.8× 67 0.9× 79 1.2× 30 589
Zuhair N. Al‐Hassnan Saudi Arabia 18 549 1.5× 38 0.2× 51 0.4× 30 0.4× 166 2.6× 78 1.0k
Shingo Ito Japan 14 178 0.5× 72 0.4× 21 0.2× 52 0.7× 61 0.9× 50 664
Fereydoun G. Sajjadi United States 9 458 1.3× 63 0.3× 62 0.5× 23 0.3× 129 2.0× 10 889
Samantha M. Carlisle United States 15 211 0.6× 34 0.2× 137 1.1× 124 1.7× 23 0.4× 23 545
Víctor Llombart Spain 14 384 1.1× 32 0.2× 74 0.6× 83 1.1× 39 0.6× 19 734
Ei‐ichi Matsuo Japan 10 202 0.6× 93 0.5× 26 0.2× 28 0.4× 80 1.2× 14 417

Countries citing papers authored by Peter Kupchak

Since Specialization
Citations

This map shows the geographic impact of Peter Kupchak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Kupchak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Kupchak more than expected).

Fields of papers citing papers by Peter Kupchak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Kupchak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Kupchak. The network helps show where Peter Kupchak may publish in the future.

Co-authorship network of co-authors of Peter Kupchak

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Kupchak. A scholar is included among the top collaborators of Peter Kupchak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Kupchak. Peter Kupchak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Esplin, M. Sean, et al.. (2019). Prospective evaluation of the efficacy of immunoassays in the diagnosis of rupture of the membranes. The Journal of Maternal-Fetal & Neonatal Medicine. 33(15). 2594–2600. 1 indexed citations
3.
Berinstein, Jeffrey, Calen A. Steiner, Athos Bousvaros, et al.. (2019). The Clinical Accuracy of the BÜHLMANN fCAL ELISA in the Differentiation of Inflammatory Bowel Disease From Irritable Bowel Syndrome: A Multicenter Prospective Case–Control Study. Crohn s & Colitis 360. 1(3). 3 indexed citations
4.
Khella, Heba, Henriett Butz, Qiang Ding, et al.. (2015). miR-221/222 Are Involved in Response to Sunitinib Treatment in Metastatic Renal Cell Carcinoma. Molecular Therapy. 23(11). 1748–1758. 63 indexed citations
5.
Heng, Yujing J., Lorne Taylor, Brett Larsen, et al.. (2014). Albumin Decrease Is Associated with Spontaneous Preterm Delivery within 48 h in Women with Threatened Preterm Labor. Journal of Proteome Research. 14(1). 457–466. 9 indexed citations
6.
Lichner, Zsuzsanna, Annika Fendler, Sahar Al‐Haddad, et al.. (2013). MicroRNA Signature Helps Distinguish Early from Late Biochemical Failure in Prostate Cancer. Clinical Chemistry. 59(11). 1595–1603. 47 indexed citations
7.
Cawthorn, Thomas R., Juan Carlos Alvarez Moreno, Moyez Dharsee, et al.. (2012). Proteomic Analyses Reveal High Expression of Decorin and Endoplasmin (HSP90B1) Are Associated with Breast Cancer Metastasis and Decreased Survival. PLoS ONE. 7(2). e30992–e30992. 70 indexed citations
8.
Borg, Keith, Jordan Bonomo, Edward C. Jauch, et al.. (2012). Serum Levels of Biochemical Markers of Traumatic Brain Injury. 2012. 1–7. 10 indexed citations
9.
Vaccarino, Anthony L., Terrence Sills, Karen E. Anderson, et al.. (2011). Assessment of Depression, Anxiety and Apathy in Prodromal and Early Huntington Disease. PLoS Currents. 3. RRN1242–RRN1242. 11 indexed citations
10.
Vaccarino, Anthony L., Terrence Sills, Karen E. Anderson, et al.. (2011). Assessment of Motor Symptoms and Functional Impact in Prodromal and Early Huntington Disease. PLoS Currents. 2. RRN1244–RRN1244. 6 indexed citations
11.
Vaccarino, Anthony L., Terrence Sills, Karen E. Anderson, et al.. (2011). Assessment of Day-to-Day Functioning in Prodromal and Early Huntington Disease. PLoS Currents. 3. RRN1262–RRN1262. 12 indexed citations
12.
Vaccarino, Anthony L., Terrence Sills, Karen E. Anderson, et al.. (2011). Assessment of Cognitive Symptoms in Prodromal and Early Huntington Disease. PLoS Currents. 3. RRN1250–RRN1250. 14 indexed citations
13.
Vaccarino, Anthony L., Karen E. Anderson, Beth Borowsky, et al.. (2011). Assessing Behavioural Manifestations Prior to Clinical Diagnosis of Huntington Disease: "Anger and Irritability" and "Obsessions and Compulsions". PLoS Currents. 3. RRN1241–RRN1241. 5 indexed citations
14.
Kupchak, Peter, Alan H.B. Wu, Farooq Ghani, et al.. (2006). Influence of Imprecision on ROC Curve Analysis for Cardiac Markers. Clinical Chemistry. 52(4). 752–753. 24 indexed citations
15.
Stanton, Eric, Mark Hansen, Harindra C. Wijeysundera, et al.. (2004). A Direct Comparison of the Natriuretic Peptides and Their Relationship to Survival in Chronic Heart Failure of a Presumed Non-Ischaemic Origin. European Journal of Heart Failure. 7(4). 557–565. 27 indexed citations
16.
Zhang, Rulin, Deborah Pinchev, John Marshall, et al.. (2004). Mining biomarkers in human sera using proteomic tools. PROTEOMICS. 4(1). 244–256. 144 indexed citations
17.
Marshall, John, Peter Kupchak, Weimin Zhu, et al.. (2003). Processing of Serum Proteins Underlies the Mass Spectral Fingerprinting of Myocardial Infarction. Journal of Proteome Research. 2(4). 361–372. 174 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026